sk&f 86002 has been researched along with mocetinostat in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
Clayton, MK; Cooley, AJ; Darien, BJ; Hart, AP; Kruse-Elliott, KT; MacWilliams, PS; Schram, BR; Triplett, EA | 1 |
2 other study(ies) available for sk&f 86002 and mocetinostat
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
SK&F 86002, a dual cytokine and eicosanoid inhibitor, attenuates endotoxin-induced cardiopulmonary dysfunction in the pig.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Eicosanoids; Endotoxemia; Heart; Imidazoles; Lipopolysaccharides; Lung; Peroxidase; Stroke Volume; Swine; Thiazoles; Thromboxanes; Tumor Necrosis Factor-alpha; Vascular Resistance | 1996 |